Arthritis Blog Home»Psoriatic Arthritis Blog Home» Tag Archives: psoriatic arthritis medication
Keep up-to-date on the latestpsoriatic arthritis (PsA) researchwith our brief research summaries.
PsA Increases Diabetes Risk
Having PsA may increase yourrisk of diabetes, according to recent research. In a study of 1,305 PsA patients seen in a large specialty clinic between January 1978 and November 2014, Canadian researchers found their risk of developing diabetes was 43% higher than for the general population. The risk was greatest among those with the highest levels of PsA activity, suggesting inflammation may be a common thread in the two diseases.
Source:The Journal of Rheumatology, published online February 2017
Continue readingPsA Research Briefs: Diabetes, Surgery, Fibromyalgia→
Keep up-to-date on the latestpsoriatic arthritis (PsA)research with our brief research summaries.
Nail Changes May Indicate Psoriatic Arthritis
Certain nail features can help doctors distinguish betweenpsoriasis and psoriatic arthritis, and possibly lead to earlier or improved treatment for PsA, a new study suggests. In the analysis of 1,092 patients with either PsA or psoriasis only, researchers found that nail changes were more common among those with PsA than psoriasis only. Transverse (side-to-side) grooves, splinter hemorrhages (small broken blood vessels under the nails) and onycholysis (separation of the nail from the nail bed) were associated with arthritis. Transverse grooves were significantly associated with arthritis in the joint closest to the nail and enthesitis, inflammation where the tendons and ligaments insert into the bone.
Source: Journal of the American Academy of Dermatology, November 2017
Continue readingPsoriatic Arthritis Research Briefs: Nail Changes, New Biologic, Biosimilar→
Good news for the approximately two million Americans withpsoriatic arthritis (PsA). Those with active disease now have two new treatment options: the U.S. Food and Drug Administration (FDA) in December approved both ixekizumab (Taltz) and tofacitinib (Xeljanz) for thetreatment of PsA.
Continue readingFDA Approves Two New Drugs for Psoriatic Arthritis→
